exendin based glp 1 Exendin-4(1-32)K-Capric Acid, a Glucagon-Like Peptide-1 Receptor Agonist, Suppresses Food Intake via Arcuate Pro-Opiomelanocortin Neurons Achieve your results faster with highly validated Exendin-4 gene modification and microscaffold

This contributes to increased satiety and reduced appetite, often resulting in weight lossa beneficial effect for many patients with type 2 diabetes who are overweight or obese

Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior

The GIP-1 agonist part of tirzepatide works in a similar way as GLP-1 agonists

HGF protein benefits are largely dependent on the way of administration, mostly due to HGF short half-life and poor accessibility to the BBB

Wegovy (semaglutide 2.4 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or obstructive sleep apnoea